Literature DB >> 8529997

Evaluation of G-to-A substitution in the apolipoprotein A-I gene promoter as a determinant of high-density lipoprotein cholesterol level in subjects with and without cholesteryl ester transfer protein deficiency.

H Akita1, H Chiba, M Tsuji, S P Hui, Y Takahashi, K Matsuno, K Kobayashi.   

Abstract

The effect of a polymorphism, guanine (G) to adenine (A) substitution in the promoter of apolipoprotein A-I gene at a position 78 bp upstream of the transcription initiation site, on the serum high-density lipoprotein (HDL)-cholesterol level was studied in 168 Japanese subjects with HDL-cholesterol levels ranging from 26 to 171 mg/dl. Considering the significant effect of cholesteryl ester transfer protein (CETP) on the HDL-cholesterol level and the common occurrence of its deficiency, we performed statistical analyses separately for two groups: one without CETP deficiency (n = 126) and the other with CETP deficiency (n = 42). In the group without CETP deficiency, in which the numbers of G/G, G/A, and A/A genotypes were 92 (73.0%), 28 (22.2%), and 6 (4.8%), respectively, the frequency of the A allele in the subjects with HDL-cholesterol levels of > or = 70 mg/dl did not differ from subjects with HDL-cholesterol levels of < or = 69 mg/dl, irrespective of gender: 0.154 and 0.145 in males, and 0.182 and 0.174 in females, respectively, for the > or = 70 mg/dl and < or = 69 mg/dl groups. Additionally, the HDL-cholesterol levels for the subjects with the G/G genotype did not differ from those for the subjects with the A allele: 64 +/- 22, 58 +/- 14, 77 +/- 14 and 62 +/- 16 mg/dl, respectively, for the G/G, G/A, A/A, and G/A + A/A in males, and 72 +/- 18, 74 +/- 24, 63 +/- 4, and 73 +/- 23 mg/dl in females. For the group with CETP deficiency, in which the numbers of G/G and G/A + A/A genotypes were 25 (59.5%) and 17 (40.5%), the HDL-cholesterol levels also did not differ: 98 +/- 24 mg/dl and 99 +/- 30 mg/dl, respectively, for the G/G and G/A + A/A genotypes. Thus, there is no evidence that the polymorphism has any effect on serum HDL-cholesterol levels regardless of CETP status. We conclude that the G-to-A substitution in the promoter of apolipoprotein A-I gene does not significantly alter serum HDL-cholesterol level.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8529997     DOI: 10.1007/bf00197405

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  43 in total

1.  Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease.

Authors:  J M Ordovas; F Civeira; J Genest; S Craig; A H Robbins; T Meade; M Pocovi; P M Frossard; U Masharani; P W Wilson
Journal:  Atherosclerosis       Date:  1991-03       Impact factor: 5.162

2.  Binding of plasma-derived lipid transfer protein to lipoprotein substrates. The role of binding in the lipid transfer process.

Authors:  R E Morton
Journal:  J Biol Chem       Date:  1985-10-15       Impact factor: 5.157

3.  Inheritance of high density lipoprotein and lipoprotein lipase and hepatic lipase activity.

Authors:  T Kuusi; Y A Kesäniemi; M Vuoristo; T A Miettinen; M Koskenvuo
Journal:  Arteriosclerosis       Date:  1987 Jul-Aug

4.  Identification and characterization of a high density lipoprotein-binding protein in cell membranes by ligand blotting.

Authors:  D L Graham; J F Oram
Journal:  J Biol Chem       Date:  1987-06-05       Impact factor: 5.157

5.  Cholesteryl ester transfer protein deficiency caused by a nonsense mutation detected in the patient's macrophage mRNA.

Authors:  T Gotoda; M Kinoshita; H Shimano; K Harada; M Shimada; J Ohsuga; T Teramoto; Y Yazaki; N Yamada
Journal:  Biochem Biophys Res Commun       Date:  1993-07-15       Impact factor: 3.575

6.  Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily.

Authors:  J A Ladias; S K Karathanasis
Journal:  Science       Date:  1991-02-01       Impact factor: 47.728

7.  Different cis-acting DNA elements control expression of the human apolipoprotein AI gene in different cell types.

Authors:  K N Sastry; U Seedorf; S K Karathanasis
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

8.  G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations.

Authors:  M Jeenah; A Kessling; N Miller; S Humphries
Journal:  Mol Biol Med       Date:  1990-06

9.  Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations.

Authors:  H Paul-Hayase; M Rosseneu; D Robinson; J P Van Bervliet; J P Deslypere; S E Humphries
Journal:  Hum Genet       Date:  1992-02       Impact factor: 4.132

10.  Linkage analysis of the genetic determinants of high density lipoprotein concentrations and composition: evidence for involvement of the apolipoprotein A-II and cholesteryl ester transfer protein loci.

Authors:  X Bu; C H Warden; Y R Xia; C De Meester; D L Puppione; S Teruya; B Lokensgard; S Daneshmand; J Brown; R J Gray
Journal:  Hum Genet       Date:  1994-06       Impact factor: 4.132

View more
  3 in total

1.  Consistency of genetic inheritance mode and heritability patterns of triglyceride vs. high density lipoprotein cholesterol ratio in two Taiwanese family samples.

Authors:  Kuo-Liong Chien; Hsiu-Ching Hsu; Ta-Chen Su; Chi-Yu Yang; Yuan-Teh Lee
Journal:  BMC Genet       Date:  2003-04-23       Impact factor: 2.797

2.  ApolipoproteinA1-75 G/A (M1-) polymorphism and lipoprotein(a); anti- vs. pro-Atherogenic properties.

Authors:  Ali I Albahrani; Jannete J Usher; Mohammed Alkindi; Eileen Marks; L Ranganath; Said Al-yahyaee
Journal:  Lipids Health Dis       Date:  2007-08-06       Impact factor: 3.876

3.  Interactions of six SNPs in APOA1 gene and types of obesity on low HDL-C disease in Xinjiang pastoral area of China.

Authors:  Xinping Wang; Jia He; Heng Guo; Lati Mu; Yunhua Hu; Jiaolong Ma; Yizhong Yan; Rulin Ma; Shugang Li; Yusong Ding; Mei Zhang; Qiang Niu; Jiaming Liu; Jingyu Zhang; Shuxia Guo
Journal:  Lipids Health Dis       Date:  2017-10-02       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.